Standout Papers

Addition of Docetaxel to Oral Fluoropyrimidine Improves Efficacy in Patients With Stage III Gastric Cancer... 2019 2026 2021 2023 252
  1. Addition of Docetaxel to Oral Fluoropyrimidine Improves Efficacy in Patients With Stage III Gastric Cancer: Interim Analysis of JACCRO GC-07, a Randomized Controlled Trial (2019)
    Kazuhiro Yoshida, Yasuhiro Kodera et al. Journal of Clinical Oncology

Immediate Impact

56 standout
Sub-graph 1 of 17

Citing Papers

Digestive cancers: mechanisms, therapeutics and management
2025 Standout
Antibody–Drug Conjugates (ADCs): current and future biopharmaceuticals
2025 Standout
2 intermediate papers

Works of Narutoshi Nagao being referenced

Addition of Docetaxel to Oral Fluoropyrimidine Improves Efficacy in Patients With Stage III Gastric Cancer: Interim Analysis of JACCRO GC-07, a Randomized Controlled Trial
2019 Standout

Author Peers

Author Last Decade Papers Cites
Narutoshi Nagao 161 317 175 39 392
Tomoya Kato 214 200 54 34 438
Yukiko Morinaga 161 228 54 46 392
Shigeto Koizumi 255 171 108 35 449
Paschalis Chatzipantelis 138 101 52 31 380
Birendra Kumar Sah 172 258 121 30 402
Masao Fujiwara 289 126 38 44 424
Akinori Watanabe 205 147 50 56 385
P. Sandbichler 290 188 47 26 450
Hidefumi Shiroshita 217 249 117 58 405
Yong Fang 138 205 99 41 386

All Works

Loading papers...

Rankless by CCL
2026